FDA Drug Application (021003) for EPIVIR-HBV by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number021003
Product Number001
FormTABLET;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEPIVIR-HBV
Active IngredientLAMIVUDINE



Back to FDA Applications sponsored by GLAXOSMITHKLINE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.